COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
NASDAQ:COLL - Nasdaq - US19459J1043 - Common Stock - Currency: USD
COLL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. COLL scores excellent on profitability, but there are some minor concerns on its financial health. COLL scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year COLL was profitable.
COLL had a positive operating cash flow in the past year.
COLL had positive earnings in 4 of the past 5 years.
Each year in the past 5 years COLL had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 2.69%, COLL belongs to the best of the industry, outperforming 84.46% of the companies in the same industry.
The Return On Equity of COLL (18.72%) is better than 91.19% of its industry peers.
COLL has a Return On Invested Capital of 8.30%. This is amongst the best in the industry. COLL outperforms 85.49% of its industry peers.
The Average Return On Invested Capital over the past 3 years for COLL is below the industry average of 14.98%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 18.72% | ||
| ROIC | 8.3% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
COLL's Profit Margin of 6.61% is amongst the best of the industry. COLL outperforms 84.46% of its industry peers.
In the last couple of years the Profit Margin of COLL has declined.
COLL has a Operating Margin of 21.39%. This is amongst the best in the industry. COLL outperforms 88.08% of its industry peers.
In the last couple of years the Operating Margin of COLL has grown nicely.
Looking at the Gross Margin, with a value of 57.69%, COLL is in the better half of the industry, outperforming 66.84% of the companies in the same industry.
In the last couple of years the Gross Margin of COLL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.39% | ||
| PM (TTM) | 6.61% | ||
| GM | 57.69% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
COLL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, COLL has less shares outstanding
Compared to 5 years ago, COLL has less shares outstanding
The debt/assets ratio for COLL has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.04, we must say that COLL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.04, COLL perfoms like the industry average, outperforming 58.55% of the companies in the same industry.
The Debt to FCF ratio of COLL is 4.26, which is a neutral value as it means it would take COLL, 4.26 years of fcf income to pay off all of its debts.
COLL has a better Debt to FCF ratio (4.26) than 85.49% of its industry peers.
COLL has a Debt/Equity ratio of 3.30. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.30, COLL is doing worse than 80.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.3 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 1.04 |
ROIC/WACC0.89
WACC9.32%
2.3 Liquidity
COLL has a Current Ratio of 1.08. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of COLL (1.08) is worse than 79.79% of its industry peers.
A Quick Ratio of 1.01 indicates that COLL should not have too much problems paying its short term obligations.
COLL has a worse Quick ratio (1.01) than 74.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
COLL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.19%, which is quite impressive.
Measured over the past years, COLL shows a very strong growth in Earnings Per Share. The EPS has been growing by 154.78% on average per year.
Looking at the last year, COLL shows a quite strong growth in Revenue. The Revenue has grown by 11.41% in the last year.
The Revenue has been growing by 16.31% on average over the past years. This is quite good.
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
3.2 Future
COLL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.69% yearly.
Based on estimates for the next years, COLL will show a small growth in Revenue. The Revenue will grow by 2.64% on average per year.
EPS Next Y8.96%
EPS Next 2Y5.37%
EPS Next 3Y-1.01%
EPS Next 5Y7.69%
Revenue Next Year18.52%
Revenue Next 2Y10.44%
Revenue Next 3Y4.3%
Revenue Next 5Y2.64%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.03, which indicates a rather cheap valuation of COLL.
Based on the Price/Earnings ratio, COLL is valued cheaper than 96.37% of the companies in the same industry.
COLL is valuated cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
COLL is valuated cheaply with a Price/Forward Earnings ratio of 4.60.
Based on the Price/Forward Earnings ratio, COLL is valued cheaply inside the industry as 96.37% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of COLL to the average of the S&P500 Index (35.28), we can say COLL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.03 | ||
| Fwd PE | 4.6 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 98.45% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, COLL is valued cheaper than 96.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.39 | ||
| EV/EBITDA | 4.8 |
4.3 Compensation for Growth
COLL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of COLL may justify a higher PE ratio.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y5.37%
EPS Next 3Y-1.01%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
32.94
+3.19 (+10.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners116.69%
Inst Owner Change-0.15%
Ins Owners1.52%
Ins Owner Change3.9%
Market Cap1.06B
Analysts81.82
Price Target45.08 (36.85%)
Short Float %13.33%
Short Ratio14.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.4%
Min EPS beat(2)1.96%
Max EPS beat(2)12.85%
EPS beat(4)3
Avg EPS beat(4)5.22%
Min EPS beat(4)-0.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)13.83%
EPS beat(12)8
Avg EPS beat(12)-13.44%
EPS beat(16)8
Avg EPS beat(16)-30.16%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.62%
Revenue beat(16)6
Avg Revenue beat(16)-5.22%
PT rev (1m)0%
PT rev (3m)0.47%
EPS NQ rev (1m)-2.57%
EPS NQ rev (3m)-0.68%
EPS NY rev (1m)-11.85%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)-1.02%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.03 | ||
| Fwd PE | 4.6 | ||
| P/S | 1.59 | ||
| P/FCF | 5.39 | ||
| P/OCF | 5.34 | ||
| P/B | 4.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.8 |
EPS(TTM)6.55
EY19.88%
EPS(NY)7.16
Fwd EY21.74%
FCF(TTM)6.12
FCFY18.57%
OCF(TTM)6.17
OCFY18.74%
SpS20.67
BVpS7.29
TBVpS-23.41
PEG (NY)0.56
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 18.72% | ||
| ROCE | 12.41% | ||
| ROIC | 8.3% | ||
| ROICexc | 10.04% | ||
| ROICexgc | N/A | ||
| OM | 21.39% | ||
| PM (TTM) | 6.61% | ||
| GM | 57.69% | ||
| FCFM | 29.59% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score4
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.3 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 0.99% | ||
| Cap/Sales | 0.28% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 59.7% | ||
| Profit Quality | 447.8% | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 1.04 |
F-Score4
WACC9.32%
ROIC/WACC0.89
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.19%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%3.7%
EPS Next Y8.96%
EPS Next 2Y5.37%
EPS Next 3Y-1.01%
EPS Next 5Y7.69%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%29.41%
Revenue Next Year18.52%
Revenue Next 2Y10.44%
Revenue Next 3Y4.3%
Revenue Next 5Y2.64%
EBIT growth 1Y-25.89%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year147.2%
EBIT Next 3Y28.36%
EBIT Next 5Y14.2%
FCF growth 1Y12%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y11.99%
OCF growth 3Y25.54%
OCF growth 5Y49.12%